Abstract
The rapid growth of the biomanufacturing and bioeconomy sector has positioned it as a critical part of the global economy, with applications spanning food, chemicals, agriculture, energy, and defense materials. As the United States strives to maintain its competitive edge and secure its supply chains, addressing the increasing dominance of China in the biomanufacturing industry is crucial. This white paper proposes implementing targeted tariffs on Biomanufactured products imported from China to protect the U.S. biomanufacturing industry, safeguard national security interests, and promote domestic innovation, and competitiveness for a secure bioeconomy.
Significant federal investments through the Inflation Reduction Act and the President’s Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy highlight the renewable chemicals sector as the next critical frontier. The Biden Administration has extended the Trump Administration’s policies, garnering bipartisan support for tariffs ranging from 7.5% to 100% on various industrial products from China. Despite these tariffs, the government must do more to protect biomanufacturing sector to safeguarding U.S. businesses from unfair competition and mitigating supply chain risks, especially where no domestic producers exist for certain bio ingredients crucial in manufacturing biofuels includes sustainable aviation fuels, food, beverage, biomaterials, and pharmaceutical products. Therefore, AFCC and its member companies propose a range of 60% to 100% tariff on biomanufactured products from China.
Introduction
AFCC is a collaborative government affairs effort organized by the Kilpatrick Townsend & Stockton law firm and American Diversified Energy. AFCC was created to address policy and advocacy gaps at the federal and state levels with respect to renewable chemicals, bioplastics/biomaterials, cell-cultured food ingredients, alternative proteins, single cell protein for food and feed, enzymes, alternative fuels, biobased products, and sustainable aviation fuels sectors. AFCC member companies work on food and fiber supply chain security and sustainability, renewable chemicals, industrial biotechnology, bioplastics and biomaterials, and biofuels.
Biomanufacturing, the process of using living systems—microorganisms, enzymes, and cell culture—to produce biological molecules at commercial scale—is a rapidly expanding industry with significant implications for economic growth, public health, and national security. China has made US$3.28 Trillion in investments in this sector, becoming a leading global player. 1 The influx of Chinese Biomanufactured products into the U.S. market presents both economic challenges and potential security risks.
The U.S. biomanufacturing industry, while innovative and robust, faces growing competition from Chinese manufacturers who receive help from state subsidies, local province subsidies, lower labor costs, lower energy cost due to cheap controlled coal prices, and less stringent regulatory environments. This competitive imbalance threatens the sustainability of U.S. biomanufacturers, puts at risk the continuity of supply in the food, beverage, biofuels, biomaterials, and pharmaceutical markets, endangers domestic jobs, violates protection of intellectual property, and risks U.S. leadership in critical biotechnological innovations.
Strategies to Mitigate the Impact of the Chinese Government
Common approaches used by the US Government include changes in: fiscal policy (government spending, tax cuts), structural reforms (investment, labor and regulatory reforms), international agreements (multilateral agreements, currency coordination), monetary policy (exchange rate and interest rate coordination), and trade policies (tariffs, subsidies, free trade agreements). For the purposes of this paper, we concentrate on trade policies specific to tariffs: the rationale behind tariffs, current impact application of tariffs, and proposed tariff structure going forward.
Generally, and at surface level, tariffs are a tool implemented to protect the domestic market by making imported goods more expensive thereby encouraging consumers to buy locally produced products and support domestic industries. Rationales for supporting tariffs:
In terms of impact and application, tariffs have had a mixed impact on US industries. On one hand, they have provided some U.S. industries with a breathing space before having to compete with Chinese firms. 4 For instance, the Biden administration announced new tariffs on Chinese products, including electric vehicles (EVs), batteries, and solar panels, to give U.S. industry some respite. 5 The cost to the American economy of existing tariffs has been acknowledged by the U.S. Trade Representative (USTR). It is, however, notable that the US Industrial sector has been provided some breathing space to compete with Chinese Firms. For instance, the Biden administration announced new tariffs—extending the work of the Trump Administration—on Chinese products, including (EVs, batteries, and solar panels, to give U.S. industry some respite.
The U.S. Government has targeted Chinese tariffs on industrial sectors.
6
These tariffs are part of the U.S. Government’s efforts to counter China’s unfair trade practices. The tariffs are carefully targeted at strategic sectors where the U.S. is making historic investments to create and sustain good-paying jobs.
Proposed Tariff Structure
The proposed tariff structure should focus on specific categories of Biomanufactured products that pose the greatest risk to U.S. industry and security. These categories might include, but are not limited to: Food and Beverage Ingredients. Agricultural Bioproducts (feedstocks) Renewable Chemicals and Biobased Products Pharmaceutical and Supplement Ingredients Biomaterials and Biopolymers
The tariffs should be set at a level that within a range of 60% to 100%, which is sufficient to offset the cost advantages enjoyed by Chinese producers without imposing undue burden on U.S. consumers or businesses that rely on these imports. Given the bipartisan work conducted by the Biden and Trump Administration on tariffs and tariffs ranging from 7.5% to 100%; this begs the question of why the biomanufacturing sector is not doing more to foster innovation in our sector and protecting existing businesses from the unfair practices of the Chinese Government.
Implementation Considerations
In implementing added tariffs to protect the U.S. domestic economy while preserving our ability to innovate, the following aspects need to be considered:
Conclusion
The U.S. biomanufacturing sector is at a critical juncture. The unchecked influx of biomanufactured products from China threatens the economic viability of domestic companies, undermines national security, and stifles innovation. By implementing targeted tariffs on these products, the U.S. can protect its biomanufacturing industry, secure its supply chains, and support its leadership in this vital sector.
The time to act is now. We urge the Administration and Congress to consider this proposal and take the necessary steps to safeguard America’s biomanufacturing future.
Editor’s Note
This proposal was reprinted with permission from AFCC.
